# Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and Disability in Sub-Acute Low Back Pain

> **NCT00384371** · PHASE4 · TERMINATED · sponsor: **United States Department of Defense**

## Conditions studied

- Low Back Pain

## Interventions

- **DRUG:** Botulinum Toxin A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00384371
- **Lead sponsor:** United States Department of Defense
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding was unable to be secured for this study
- **Last updated:** 2009-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384371, "Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and Disability in Sub-Acute Low Back Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00384371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
